According to Twist Bioscience 's latest financial reports the company's total assets are $0.70 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-09-30 | $0.77 B | -19.24% |
2022-09-30 | $0.96 B | 36.93% |
2021-09-30 | $0.70 B | 76.02% |
2020-09-30 | $0.39 B | 113.31% |
2019-09-30 | $0.18 B | 61.49% |
2018-09-30 | $0.11 B | 35.18% |
2017-09-30 | $85.65 M | 12.02% |
2016-09-30 | $76.46 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $8.88 M | -98.74% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.20 B | -71.22% | ๐ฌ๐ง UK |
Novavax NVAX | $1.79 B | 155.74% | ๐บ๐ธ USA |
Novocure
NVCR | $1.12 B | 59.56% | Jersey |